Tag Archives: Clopidogrel

FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a [...]